Dare Bioscience announces additional data for Phase 2b RESPOND study
PremiumThe FlyDare Bioscience announces additional data for Phase 2b RESPOND study
1M ago
Dare Bioscience target adjusted to $12 from $6 at H.C. Wainwright
Premium
The Fly
Dare Bioscience target adjusted to $12 from $6 at H.C. Wainwright
1M ago
Daré Bioscience Announces Publication in The Journal of Sexual Medicine of Positive Findings from the Phase 2b RESPOND Clinical Study of Sildenafil Cream, 3.6%
Premium
Press Releases
Daré Bioscience Announces Publication in The Journal of Sexual Medicine of Positive Findings from the Phase 2b RESPOND Clinical Study of Sildenafil Cream, 3.6%
1M ago
Daré Bioscience Regains Nasdaq Compliance, Advances Phase 3 Trials
PremiumCompany AnnouncementsDaré Bioscience Regains Nasdaq Compliance, Advances Phase 3 Trials
2M ago
Daré Bioscience Regains Compliance with Nasdaq Minimum Bid Price Rule
Premium
Press Releases
Daré Bioscience Regains Compliance with Nasdaq Minimum Bid Price Rule
2M ago
Dare Bioscience regains compliance with Nasdaq minimum bid price rule
Premium
The Fly
Dare Bioscience regains compliance with Nasdaq minimum bid price rule
2M ago
Dare announces publication of efficacy results of topical sildenafil cream
PremiumThe FlyDare announces publication of efficacy results of topical sildenafil cream
3M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
Brookline upgrades Dare Bioscience to Buy on improved funding
Premium
The Fly
Brookline upgrades Dare Bioscience to Buy on improved funding
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100